ArticleJournal of translational medicine2022

Two for one: targeting BCMA and CD19 in B-cell malignancies with off-the-shelf dual-CAR NK-92 cells.

Gils Roex et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.